Show simple item record

dc.contributor.authorDora, José Miguel Silvapt_BR
dc.contributor.authorScheffel, Rafael Selbachpt_BR
dc.date.accessioned2012-05-03T01:26:17Zpt_BR
dc.date.issued2010pt_BR
dc.identifier.issn0004-2730pt_BR
dc.identifier.urihttp://hdl.handle.net/10183/40073pt_BR
dc.format.mimetypeapplication/pdf
dc.language.isoengpt_BR
dc.relation.ispartofArquivos brasileiros de endocrinologia & metabologia = Brazilian archives of endocrinology and metabolism. Vol. 54, n. 1 (fev. 2010), p. 82-84pt_BR
dc.rightsOpen Accessen
dc.subjectFarmacocinéticapt_BR
dc.subjectInsulina isofanapt_BR
dc.subjectCriançapt_BR
dc.subjectMétodospt_BR
dc.subjectComplicaçõespt_BR
dc.subjectPrevenção e controlept_BR
dc.subjectDiabetes mellitus tipo 1pt_BR
dc.titleTheoretical pharmacokinetic advantages and methodological flaws: glargine is not superior to NPH insulin in children with type 1 diabetes mellituspt_BR
dc.typeArtigo de periódicopt_BR
dc.identifier.nrb000755443pt_BR
dc.type.originNacionalpt_BR


Files in this item

Thumbnail
   

This item is licensed under a Creative Commons License

Show simple item record